Testosterone implants added to MIMS

on the 29 March 2011

Testosterone implants now listed in MIMS | SPL
Testosterone implants now listed in MIMS | SPL

Testosterone subcutaneous implants are now listed in MIMS.

The 100mg and 200mg implants are indicated for primary and secondary hypogonadism in males. Implants should be inserted into an area where there is relatively little movement or blood supply, such as the lower abdominal wall or buttock.

The recommended dose is 100-600mg. In most hypogonadal men a dose of 600mg maintains plasma testosterone levels within the normal physiological range for 4–5 months.

View Testosterone Implant drug record

Further information: MSD

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

The most up-to-date drug information at your fingertips.

  • Get the prescribing support you need.
  • Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Register Now
Already Registered?

Forgotten password?

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Twitter  

More from MIMS

Last chance to register for the next Respiratory and Allergy Learning Series event

Last chance to register for the next Respiratory and Allergy Learning Series event

Join Dr Steve Holmes, who will be chairing the MIMS...

Drug shortages - live tracker

Drug shortages - live tracker

Added: Accrete D3.
Use our constantly updated...

Don't prescribe antibiotics for non-bullous impetigo, draft NICE guidance advises

Don't prescribe antibiotics for non-bullous impetigo, draft NICE guidance advises

Topical antiseptics are preferable to antibiotics for...

Contraceptives

Contraceptives

Hormone doses and costs of hormonal contraceptives.